Drugs Starting with B
BioSniper tracks 95 drugs and molecules whose names begin with B — each linked to its developers, clinical trials, indications, and FDA decisions. Data availability reflects the latest successfully ingested source records; source and as-of dates are shown where available.
Browse A–ZB
- b7h3/cd3-targeting t-cell engaging molecule tak-280
- baclofen1
- balstilimab
- baricitinib2
- barzolvolimab
- batoprotafib
- bavdegalutamide1
- baxdrostat1
- bbo-10203
- bbo-11818
- bbo-8520
- bcl-2 inhibitor abbv-453
- bcl-2 inhibitor bgb-21447
- bcl-2 inhibitor loxo-338
- bcl6 degrader bms-986458
- bcx9930
- bd2-selective bet inhibitor nuv-8681
- bdc-1001
- bedaquiline
- belantamab mafodotin
- belapectin1
- belatacept3
- belcesiran1
- belimumab
- belinostat
- belrestotug2
- belumosudil1
- belzupacap sarotalocan
- belzutifan
- bemarituzumab1
- bemnifosbuvir
- bempegaldesleukin
- bempikibart1
- bendamustine
- benralizumab
- benznidazole
- beruzatatug pelitecan
- bet bromodomain inhibitor zen-3694
- bet inhibitor incb057643
- bevacizumab
- bevyxxa1
- bexarotene
- bexobrutideg2
- bexotegrast2
- bezafibrate
- bezlotoxumab
- bezuclastinib2
- bgb-16673
- bgb-b2033
- bicalutamide2
- bifunctional tgf-beta antagonist/il-15 protein complex hcw9218
- bimatoprost1
- bimekizumab
- binimetinib1
- bion-13011
- biothrax
- birelentinib
- bivalirudin2
- bivamelagon1
- bleomycin
- blinatumomab1
- bomedemstat1
- bortezomib1
- bosentan
- bosutinib
- botensilimab1
- botox
- botulinum toxin type A3
- bpx-6011
- brelovitug1
- brensocatib
- brentuximab vedotin
- brexanolone1
- brexucabtagene autoleucel
- breyanzi
- brigatinib
- brimonidine1
- briquilimab1
- briumvi1
- brivaracetam
- brolucizumab
- btk degrader abbv-101
- budesonide
- budesonide; formoterol2
- budigalimab
- bulevirtide
- bumetanide
- buparlisib
- bupivacaine1
- buprenorphine4
- buprenorphine hydrochloride; naloxone
- bupropion
- burosumab1
- busulfan2
- bxcl7011
From drug list to evidence case
Define what these drug programs must prove
Choose the developer, phase, trial, indication, and FDA evidence that should count in your drug thesis.